Home › Funds › D. E. Shaw & Co › ATRA
D. E. Shaw & Co position in ATRA
ATARA BIOTHERAPEUTICS INC · Health Care
Latest position (Q4 2023)1.03M sh
Reported value held$530.23K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 831.91K | $14.89M | New |
| Q4 2021 | 919.40K | $14.49M | Add |
| Q1 2022 | 662.96K | $6.16M | Reduce |
| Q2 2022 | 668.21K | $5.21M | Add |
| Q3 2022 | 2.72M | $10.28M | Add |
| Q4 2022 | 3.53M | $11.58M | Add |
| Q1 2023 | 4.23M | $12.27M | Add |
| Q2 2023 | 4.35M | $7.00M | Add |
| Q3 2023 | 3.91M | $5.79M | Reduce |
| Q4 2023 | 1.03M | $530.23K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ATRA
- Point72 Asset Management 687.72K sh · $7.90M · Q2 2026
- Vanguard Group 225.94K sh · $4.09M · Q4 2025
- BlackRock Inc 84.45K sh · $969.54K · Q2 2026
- Geode Capital Management 75.13K sh · $862.92K · Q2 2026
- Northern Trust Corp 16.59K sh · $190.47K · Q2 2026
- Fidelity Management & Research (FMR) 16.24K sh · $186.41K · Q2 2026
- Millennium Management 12.68K sh · $145.57K · Q2 2026
- Citadel Advisors 10.16K sh · $116.62K · Q2 2026
- Morgan Stanley 9.18K sh · $105.37K · Q2 2026
- UBS Group AG 3.98K sh · $45.68K · Q2 2026
- Wells Fargo & Co 251 sh · $2.88K · Q2 2026
- JPMorgan Chase & Co 216 sh · $2.41K · Q2 2026